Whether this observation can be attributed to an increased and prolonged sensitivity to trastuzumab-based treatment or represents an intrinsic biologic characteristic of tumours exhibiting tyr1248 phosphorylation of Her-2/neu remains to be determined in future prospective trials evaluating the predictive value of pHer-2/neu for various forms of treatment. Here, ERBB2 is linked to neoplasm.